Quetiapine use: Science or clever marketing?

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 1, 2013, Pages 96-97

  Monasterio, Erik ^a   McKean, Andrew ^a  

^a Hillmorton Hospital   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE;

CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; GENERAL PRACTITIONER; HUMAN; LETTER; PRESCRIPTION;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DRUG INDUSTRY; HUMANS; MARKETING; NEW ZEALAND; OFF-LABEL USE;

EID: 84873896968     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412455234     Document Type: Letter

References (9)

1. Crystal S, Olfson M, Huang C, et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Affairs. 2009 ; 28: w770 - w781
2. Heilbronn CE, Lloyd B, McElwee P, et al. Quetiapine-related harms on the rise. Australian and New Zealand Journal of Psychiatry. 2012 ; 46: 279-280
3. IMS Health (2010) Top 20 Global Therapeutic Products 2010, total audited markets. Available at: http://www.imshealth.com (accessed 16 August 2011).
4. Kesselheim A, Mello M, Studdert D. Strategies and practices in off-label marketing of pharmaceuticals: A retrospective analysis of whistleblower complaints. PLoS Medicine. 2011 ; 8: e1000431
5. Kmietowicz Z. Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine. British Medical Journal. 2009 ; 338: b217
6. Kuehn BM. FDA panel issues mixed decision on quetiapine in depression and anxiety. Journal of the American Medical Association. 2009 ; 301: 2081-2082
7. MonasterioEMcKeanA (2011) Off-label use of atypical antipsychotic medications in Canterbury, New Zealand. The New Zealand Medical Journal124: (1336). Available at: http://www.nzma.org.nz/journal/124-1336/4700 (accessed 20 April 2012).
8. Pierre JM, Shnayder I, Wirshing DA, et al. Intranasal quetiapine abuse. American Journal of Psychiatry. 2004 1718 ; 161 :
9. Waters BM, Joshi KG. Intravenous quetiapine-cocaine use ("Q-ball). American Journal of Psychiatry. 2007 ; 164: 173-174